A detailed history of Shelton Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Shelton Capital Management holds 78,966 shares of JNJ stock, worth $12.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
78,966
Previous 90,389 12.64%
Holding current value
$12.3 Million
Previous $14.3 Million 19.28%
% of portfolio
0.32%
Previous 0.42%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $1.65 Million - $1.8 Million
-11,423 Reduced 12.64%
78,966 $11.5 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $2.79 Million - $2.92 Million
-17,960 Reduced 16.58%
90,389 $14.3 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $1.92 Million - $2.1 Million
13,203 Added 13.88%
108,349 $17 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $1.7 Million - $1.9 Million
-10,900 Reduced 10.28%
95,146 $14.8 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $677,133 - $728,724
4,387 Added 4.32%
106,046 $17.6 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $9.46 Million - $11.3 Million
62,659 Added 160.66%
101,659 $15.8 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $7.85 Million - $8.81 Million
-49,000 Reduced 55.68%
39,000 $6.89 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $3.39 Million - $3.77 Million
20,995 Added 31.33%
88,000 $14.4 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $1.09 Million - $1.2 Million
6,456 Added 10.66%
67,005 $11.9 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $2.37 Million - $2.69 Million
15,000 Added 32.93%
60,549 $10.7 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $41,321 - $45,847
-265 Reduced 0.58%
45,549 $7.79 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $16,150 - $17,947
-100 Reduced 0.22%
45,814 $7.4 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $7.25 Million - $7.77 Million
-45,432 Reduced 49.74%
45,914 $7.56 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $7.17 Million - $7.99 Million
46,845 Added 105.27%
91,346 $15 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $126,826 - $145,576
-925 Reduced 2.04%
44,501 $7 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $367,093 - $402,265
-2,615 Reduced 5.44%
45,426 $6.76 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $2.15 Million - $2.6 Million
16,700 Added 53.28%
48,041 $6.76 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $243,285 - $337,084
-2,189 Reduced 6.53%
31,341 $4.11 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $210,375 - $241,626
1,650 Added 5.18%
33,530 $4.89 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $88,865 - $99,497
-700 Reduced 2.15%
31,880 $4.13 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $3.65 Million - $4.02 Million
27,844 Added 587.92%
32,580 $4.54 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $3.81 Million - $4.24 Million
-30,330 Reduced 86.49%
4,736 $33.9 Million
Q4 2018

Jan 31, 2019

BUY
$122.84 - $147.84 $127,139 - $153,014
1,035 Added 3.04%
35,066 $4.53 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $30,395 - $35,720
250 Added 0.74%
34,031 $4.7 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $171,219 - $188,943
-1,434 Reduced 4.07%
33,781 $4.1 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $168,384 - $199,396
-1,346 Reduced 3.68%
35,215 $4.51 Million
Q4 2017

Feb 06, 2018

SELL
$131.22 - $143.62 $443,786 - $485,722
-3,382 Reduced 8.47%
36,561 $5.11 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $88,945 - $93,006
-687 Reduced 1.69%
39,943 $5.19 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-15,752 Reduced 27.94%
40,630 $5.38 Million
Q1 2017

Nov 28, 2017

SELL
N/A
-16,839 Reduced 23.0%
56,382 $7.02 Million
Q4 2016

Nov 29, 2017

BUY
N/A
11,207 Added 18.07%
73,221 $8.44 Million
Q3 2016

Dec 06, 2017

SELL
N/A
-11,207 Reduced 15.31%
62,014 $7.33 Million
Q3 2016

Dec 04, 2017

BUY
N/A
73,221
73,221 $8.44 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.